Iterum Therapeutics plc — Director's Dealing 2018

May 29, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2018-05-24

Reporting Person: Edick Paul R (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-24	Restricted Stock Units	$	A	6154	Acquired		Ordinary Shares (6154)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Ordinary Shares.

F2: Subject to the Reporting Person providing continuous service, the RSU shall vest on May 24, 2019.